Assessment of esophageal adenocarcinoma risk using somatic chromosome alterations in longitudinal samples in Barrett's esophagus

Xiaohong Li, Thomas G. Paulson, Patricia C. Galipeau, Carissa A. Sanchez, Karen Liu, Mary K. Kuhner, Carlo Maley, Steven G. Self, Thomas L. Vaughan, Brian J. Reid, Patricia L. Blount

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Cancers detected at a late stage are often refractory to treatments and ultimately lethal. Early detection can significantly increase survival probability, but attempts to reduce mortality by early detection have frequently increased overdiagnosis of indolent conditions that do not progress over a lifetime. Study designs that incorporate biomarker trajectories in time and space are needed to distinguish patients who progress to an early cancer from those who follow an indolent course. Esophageal adenocarcinoma is characterized by evolution of punctuated and catastrophic somatic chromosomal alterations and high levels of overall mutations but few recurrently mutated genes aside from TP53. Endoscopic surveillance of Barrett's esophagus for early cancer detection provides an opportunity for assessment of alterations for cancer risk in patients who progress to esophageal adenocarcinoma compared with nonprogressors. We investigated 1,272 longitudinally collected esophageal biopsies in a 248 Barrett's patient case-cohort study with 20,425 person-months of follow-up, including 79 who progressed to early-stage esophageal adenocarcinoma. Cancer progression risk was assessed for total chromosomal alterations, diversity, and chromosomal region-specific alterations measured with single-nucleotide polymorphism arrays in biopsies obtained over esophageal space and time. A model using 29 chromosomal features was developed for cancer risk prediction (area under receiver operator curve, 0.94). The model prediction performance was robust in two independent esophageal adenocarcinoma sets and outperformed TP53 mutation, flow cytometric DNA content, and histopathologic diagnosis of dysplasia. This study offers a strategy to reduce overdiagnosis in Barrett's esophagus and improve early detection of esophageal adenocarcinoma and potentially other cancers characterized by punctuated and catastrophic chromosomal evolution.

Original languageEnglish (US)
Pages (from-to)845-856
Number of pages12
JournalCancer Prevention Research
Volume8
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Barrett Esophagus
Adenocarcinoma
Chromosomes
Neoplasms
Biopsy
Mutation
p53 Genes
Esophageal Neoplasms
Single Nucleotide Polymorphism
Cohort Studies
Biomarkers
Survival
Mortality
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Assessment of esophageal adenocarcinoma risk using somatic chromosome alterations in longitudinal samples in Barrett's esophagus. / Li, Xiaohong; Paulson, Thomas G.; Galipeau, Patricia C.; Sanchez, Carissa A.; Liu, Karen; Kuhner, Mary K.; Maley, Carlo; Self, Steven G.; Vaughan, Thomas L.; Reid, Brian J.; Blount, Patricia L.

In: Cancer Prevention Research, Vol. 8, No. 9, 01.09.2015, p. 845-856.

Research output: Contribution to journalArticle

Li, X, Paulson, TG, Galipeau, PC, Sanchez, CA, Liu, K, Kuhner, MK, Maley, C, Self, SG, Vaughan, TL, Reid, BJ & Blount, PL 2015, 'Assessment of esophageal adenocarcinoma risk using somatic chromosome alterations in longitudinal samples in Barrett's esophagus', Cancer Prevention Research, vol. 8, no. 9, pp. 845-856. https://doi.org/10.1158/1940-6207.CAPR-15-0130
Li, Xiaohong ; Paulson, Thomas G. ; Galipeau, Patricia C. ; Sanchez, Carissa A. ; Liu, Karen ; Kuhner, Mary K. ; Maley, Carlo ; Self, Steven G. ; Vaughan, Thomas L. ; Reid, Brian J. ; Blount, Patricia L. / Assessment of esophageal adenocarcinoma risk using somatic chromosome alterations in longitudinal samples in Barrett's esophagus. In: Cancer Prevention Research. 2015 ; Vol. 8, No. 9. pp. 845-856.
@article{4d8faa3d2a76437982e524454165e26a,
title = "Assessment of esophageal adenocarcinoma risk using somatic chromosome alterations in longitudinal samples in Barrett's esophagus",
abstract = "Cancers detected at a late stage are often refractory to treatments and ultimately lethal. Early detection can significantly increase survival probability, but attempts to reduce mortality by early detection have frequently increased overdiagnosis of indolent conditions that do not progress over a lifetime. Study designs that incorporate biomarker trajectories in time and space are needed to distinguish patients who progress to an early cancer from those who follow an indolent course. Esophageal adenocarcinoma is characterized by evolution of punctuated and catastrophic somatic chromosomal alterations and high levels of overall mutations but few recurrently mutated genes aside from TP53. Endoscopic surveillance of Barrett's esophagus for early cancer detection provides an opportunity for assessment of alterations for cancer risk in patients who progress to esophageal adenocarcinoma compared with nonprogressors. We investigated 1,272 longitudinally collected esophageal biopsies in a 248 Barrett's patient case-cohort study with 20,425 person-months of follow-up, including 79 who progressed to early-stage esophageal adenocarcinoma. Cancer progression risk was assessed for total chromosomal alterations, diversity, and chromosomal region-specific alterations measured with single-nucleotide polymorphism arrays in biopsies obtained over esophageal space and time. A model using 29 chromosomal features was developed for cancer risk prediction (area under receiver operator curve, 0.94). The model prediction performance was robust in two independent esophageal adenocarcinoma sets and outperformed TP53 mutation, flow cytometric DNA content, and histopathologic diagnosis of dysplasia. This study offers a strategy to reduce overdiagnosis in Barrett's esophagus and improve early detection of esophageal adenocarcinoma and potentially other cancers characterized by punctuated and catastrophic chromosomal evolution.",
author = "Xiaohong Li and Paulson, {Thomas G.} and Galipeau, {Patricia C.} and Sanchez, {Carissa A.} and Karen Liu and Kuhner, {Mary K.} and Carlo Maley and Self, {Steven G.} and Vaughan, {Thomas L.} and Reid, {Brian J.} and Blount, {Patricia L.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1158/1940-6207.CAPR-15-0130",
language = "English (US)",
volume = "8",
pages = "845--856",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Assessment of esophageal adenocarcinoma risk using somatic chromosome alterations in longitudinal samples in Barrett's esophagus

AU - Li, Xiaohong

AU - Paulson, Thomas G.

AU - Galipeau, Patricia C.

AU - Sanchez, Carissa A.

AU - Liu, Karen

AU - Kuhner, Mary K.

AU - Maley, Carlo

AU - Self, Steven G.

AU - Vaughan, Thomas L.

AU - Reid, Brian J.

AU - Blount, Patricia L.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Cancers detected at a late stage are often refractory to treatments and ultimately lethal. Early detection can significantly increase survival probability, but attempts to reduce mortality by early detection have frequently increased overdiagnosis of indolent conditions that do not progress over a lifetime. Study designs that incorporate biomarker trajectories in time and space are needed to distinguish patients who progress to an early cancer from those who follow an indolent course. Esophageal adenocarcinoma is characterized by evolution of punctuated and catastrophic somatic chromosomal alterations and high levels of overall mutations but few recurrently mutated genes aside from TP53. Endoscopic surveillance of Barrett's esophagus for early cancer detection provides an opportunity for assessment of alterations for cancer risk in patients who progress to esophageal adenocarcinoma compared with nonprogressors. We investigated 1,272 longitudinally collected esophageal biopsies in a 248 Barrett's patient case-cohort study with 20,425 person-months of follow-up, including 79 who progressed to early-stage esophageal adenocarcinoma. Cancer progression risk was assessed for total chromosomal alterations, diversity, and chromosomal region-specific alterations measured with single-nucleotide polymorphism arrays in biopsies obtained over esophageal space and time. A model using 29 chromosomal features was developed for cancer risk prediction (area under receiver operator curve, 0.94). The model prediction performance was robust in two independent esophageal adenocarcinoma sets and outperformed TP53 mutation, flow cytometric DNA content, and histopathologic diagnosis of dysplasia. This study offers a strategy to reduce overdiagnosis in Barrett's esophagus and improve early detection of esophageal adenocarcinoma and potentially other cancers characterized by punctuated and catastrophic chromosomal evolution.

AB - Cancers detected at a late stage are often refractory to treatments and ultimately lethal. Early detection can significantly increase survival probability, but attempts to reduce mortality by early detection have frequently increased overdiagnosis of indolent conditions that do not progress over a lifetime. Study designs that incorporate biomarker trajectories in time and space are needed to distinguish patients who progress to an early cancer from those who follow an indolent course. Esophageal adenocarcinoma is characterized by evolution of punctuated and catastrophic somatic chromosomal alterations and high levels of overall mutations but few recurrently mutated genes aside from TP53. Endoscopic surveillance of Barrett's esophagus for early cancer detection provides an opportunity for assessment of alterations for cancer risk in patients who progress to esophageal adenocarcinoma compared with nonprogressors. We investigated 1,272 longitudinally collected esophageal biopsies in a 248 Barrett's patient case-cohort study with 20,425 person-months of follow-up, including 79 who progressed to early-stage esophageal adenocarcinoma. Cancer progression risk was assessed for total chromosomal alterations, diversity, and chromosomal region-specific alterations measured with single-nucleotide polymorphism arrays in biopsies obtained over esophageal space and time. A model using 29 chromosomal features was developed for cancer risk prediction (area under receiver operator curve, 0.94). The model prediction performance was robust in two independent esophageal adenocarcinoma sets and outperformed TP53 mutation, flow cytometric DNA content, and histopathologic diagnosis of dysplasia. This study offers a strategy to reduce overdiagnosis in Barrett's esophagus and improve early detection of esophageal adenocarcinoma and potentially other cancers characterized by punctuated and catastrophic chromosomal evolution.

UR - http://www.scopus.com/inward/record.url?scp=84941786299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941786299&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-15-0130

DO - 10.1158/1940-6207.CAPR-15-0130

M3 - Article

C2 - 26130253

AN - SCOPUS:84941786299

VL - 8

SP - 845

EP - 856

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 9

ER -